Bacillus coagulans regulates gut microbiota and ameliorates the alcoholic-associated liver disease in mice
Authors:
Open Access
- 26 February 2024
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 15, 1337185
Abstract
Introduction: Alcoholic-associated liver diseases (ALD) are now widespread issues worldwide. Alcoholic-induced chronic dysbiosis of the gut microbiota is one of the factors in the pathophysiology of ALD.Methods: In this work, we employed a chronic-binge ethanol feeding mice model, as described in a previous report.Results: Our findings demonstrate that hepatic inflammatory injury damage and accumulation of fat can be effectively reduced in mice with ALD by altering the gut microbiota utilizing Bacillus coagulans. Treatment with B. coagulans significantly modulates the levels of TNF-α, IL-1β, and IL-22 cytokines while maintaining tight junction proteins and mucin protein expressions to support intestinal barrier function restoration. Treatment with B. coagulans also alters the composition of the gut microbiota and increases the production of short-chain fatty acids (SCFAs).Discussion: This is mostly due to B. coagulans promotes the growth of bacteria that produce SCFAs, such as Ruminococcus species and Akkermansia, while inhibiting the growth of pathogenic bacteria like Escherichia Shigella. Moreover, treatment with B. coagulans causes levels of 2-Ketobutyric acid, ketoleucine, and indoleacetic acid increase while homovanillic acid and 3’-O-Methylguanosine metabolites decrease significantly. This study facilitates the development of therapeutic and preventive strategies for ALD using lactic acid bacteria.Keywords
This publication has 55 references indexed in Scilit:
- An Open‐Label, Dose‐Escalation Study to Assess the Safety and Efficacy of IL‐22 Agonist F‐652 in Patients With Alcohol‐associated HepatitisHepatology, 2020
- Synbiotic supplementation with prebiotic green banana resistant starch and probiotic Bacillus coagulans spores ameliorates gut inflammation in mouse model of inflammatory bowel diseasesEuropean Journal of Nutrition, 2020
- The role of cytochrome P4502E1 in the pathogenesis of alcoholic liver disease and carcinogenesisChemico-Biological Interactions, 2020
- Serum metabolomics for early diagnosis of esophageal squamous cell carcinoma by UHPLC-QTOF/MSMetabolomics, 2016
- Intestinal REG3 Lectins Protect against Alcoholic Steatohepatitis by Reducing Mucosa-Associated Microbiota and Preventing Bacterial TranslocationCell Host & Microbe, 2016
- Interleukin‐1 and inflammasomes in alcoholic liver disease/acute alcoholic hepatitis and nonalcoholic fatty liver disease/nonalcoholic steatohepatitisHepatology, 2016
- Therapeutic potential of interleukin 1 inhibitors in the treatment of alcoholic liver diseaseHepatology, 2013
- Deficiency of intestinal mucin-2 ameliorates experimental alcoholic liver disease in miceHepatology, 2013
- Enteric dysbiosis associated with a mouse model of alcoholic liver diseaseHepatology, 2010
- Interleukin-22 Treatment Ameliorates Alcoholic Liver Injury in a Murine Model of Chronic-Binge Ethanol Feeding: Role of Signal Transducer and Activator of Transcription 3Hepatology, 2010